Barclays PLC Surmodics Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Surmodics Inc stock. As of the latest transaction made, Barclays PLC holds 88,750 shares of SRDX stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,750

Previous 88,750 -0.0%

Holding current value

$3.02 Million

Previous $3.44 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$38.47 - $42.24 $472,065 - $518,327	12,271 Added 16.04%	88,750 $3.44 Million
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $1.7 Million - $2.81 Million	66,824 Added 692.12%	76,479 $3.22 Million
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $253,929 - $329,072	-9,254 Reduced 48.94%	9,655 $283,000
Q4 2023 Feb 15, 2024	BUY	$28.47 - $38.49 $469,527 - $634,777	16,492 Added 682.33%	18,909 $687,000
Q3 2023 Nov 07, 2023	SELL	$28.28 - $38.36 $9,106 - $12,351	-322 Reduced 11.76%	2,417 $78,000
Q2 2023 Aug 03, 2023	SELL	$17.67 - $31.31 $73,454 - $130,155	-4,157 Reduced 60.28%	2,739 $85,000
Q1 2023 May 04, 2023	BUY	$17.13 - $38.52 $3,819 - $8,589	223 Added 3.34%	6,896 $157,000
Q4 2022 Feb 13, 2023	BUY	$29.44 - $37.31 $90,056 - $114,131	3,059 Added 84.64%	6,673 $228,000
Q3 2022 Nov 03, 2022	SELL	$28.84 - $38.92 $135,807 - $183,274	-4,709 Reduced 56.58%	3,614 $110,000
Q2 2022 Aug 12, 2022	SELL	$33.25 - $45.11 $226,366 - $307,108	-6,808 Reduced 44.99%	8,323 $310,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $163,859 - $200,272	-4,028 Reduced 21.02%	15,131 $687,000
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $236,834 - $315,705	5,481 Added 40.07%	19,159 $922,000
Q3 2021 Nov 09, 2021	BUY	$52.8 - $60.32 $325,248 - $371,571	6,160 Added 81.94%	13,678 $760,000
Q2 2021 Aug 13, 2021	SELL	$51.29 - $59.15 $488,229 - $563,048	-9,519 Reduced 55.87%	7,518 $408,000
Q1 2021 May 13, 2021	BUY	$42.18 - $56.07 $85,414 - $113,541	2,025 Added 13.49%	17,037 $955,000
Q4 2020 Feb 11, 2021	SELL	$35.18 - $43.52 $49,076 - $60,710	-1,395 Reduced 8.5%	15,012 $653,000
Q3 2020 Nov 12, 2020	BUY	$37.98 - $48.72 $160,427 - $205,793	4,224 Added 34.67%	16,407 $639,000
Q2 2020 Aug 12, 2020	BUY	$31.07 - $44.74 $32,623 - $46,977	1,050 Added 9.43%	12,183 $527,000
Q1 2020 May 13, 2020	SELL	$22.46 - $42.24 $201,803 - $379,526	-8,985 Reduced 44.66%	11,133 $371,000
Q4 2019 Feb 10, 2020	BUY	$39.01 - $47.51 $63,274 - $77,061	1,622 Added 8.77%	20,118 $834,000
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $601,936 - $738,173	-15,570 Reduced 45.71%	18,496 $846,000
Q2 2019 Aug 14, 2019	SELL	$38.23 - $47.43 $53,980 - $66,971	-1,412 Reduced 3.98%	34,066 $1.47 Million
Q1 2019 May 15, 2019	SELL	$41.26 - $58.35 $241,742 - $341,872	-5,859 Reduced 14.17%	35,478 $1.54 Million
Q4 2018 Feb 14, 2019	SELL	$44.93 - $73.38 $473,023 - $772,544	-10,528 Reduced 20.3%	41,337 $1.95 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $1.55 Million - $2.19 Million	27,209 Added 110.35%	51,865 $3.87 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $488,133 - $776,792	13,616 Added 123.33%	24,656 $1.36 Million
Q1 2018 May 15, 2018	BUY	$27.0 - $38.5 $239,409 - $341,379	8,867 Added 408.05%	11,040 $420,000
Q4 2017 Feb 14, 2018	BUY	$28.0 - $33.2 $41,804 - $49,567	1,493 Added 219.56%	2,173 $61,000
Q3 2017 Nov 14, 2017	BUY	$24.5 - $31.1 $16,660 - $21,148	680	680 $21,000

Others Institutions Holding SRDX

# of Institutions

128

Shares Held

11.8M

Call Options Held

1.4K

Put Options Held

8.6K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account